Individual Study / UNM PCTSN

UNM Pediatric Clinical Trial Sites in Idea State Pediatric Clinical Trail Network

UNM Pediatric Clinical Trial Sites in Idea State Pediatric Clinical Trail Network

Initiatives -
UNM PCTSN will provide the research infrastructure as well as the supervised professional development inresearch and clinical trial implementation. We will build a dedicated pediatric clinical trial teams at ourinstitutions and will partner with IDeA and non-IDeA state institutions to improve access to relevant populationsand accelerate overall study accrual and retention of participants; our effort will have a sustained influence onchild health and advancing knowledge in the field. Our impact is significant because: 1. UNM PCTS will be a portal of entry to our diverse patient populations including underrepresented racial and ethnic groups as well as geographically isolated and under-resourced rural communities. Our community-engaged approach strengthens recruitment of these diverse populations into research studies and will improve health among pediatric populations. 2. UNM PCTS is a needed asset locally and regionally. UNM PCTS will devote a structured and skilled research team including trained investigators to conduct pediatric clinical trials. 3. UNM PCTS will bring unique capabilities to the Institutional Development Awards (IDeA) States Pediatric Clinical Trials Network (ISPCTN), including collaboration with the Clinical and Translational Research Infrastructure Network (CTR-IN) through our Clinical and Translational Science Award (CTSA) Mountain West Research Consortium (MWRC). Our clinical site will be a hub for other IDeA and non- IDeA sites; it will increase opportunity for partner sites to participate in pediatric clinical trials as they would contribute to accelerated patient enrollment and increase diversity of the patient population. 4. We have unique and established strengths in clinical study infrastructure and Translational Workforce Development (TWD) as part of UNM Clinical and Translational Science Center (CTSC) that will provide valuable assets to the entire ISPCTN. 5. Finally, UNM PCTS will have experienced principal investigators (PIs) participating in multisite pediatric clinical trials and recruitment and retention from communities and rural areas statewide. They will be a great asset to the ISPCTN Network and Steering Committee.
Start Year
End Year
National Institutes of Health (NIH)


Investigators Contacts
  • Dr. Hengameh H. Raissy
    University of New Mexico


Study design
Clinical trial cohort

Marker Paper

Fitzpatrick AM, Jackson DJ, Mauger DT, Boehmer SJ, Phipatanakul W, Sheehan WJ, Moy JN, Paul IM, Bacharier LB, Cabana MD, Covar R, Holguin F, Lemanske RF Jr, Martinez FD, Pongracic JA, Beigelman A, Baxi SN, Benson M, Blake K, Chmiel JF, Daines CL, Daines MO, Gaffin JM, Gentile DA, Gower WA, Israel E, Kumar HV, Lang JE, Lazarus SC, Lima JJ, Ly N, Marbin J, Morgan W, Myers RE, Olin JT, Peters SP, Raissy HH, Robison RG, Ross K, Sorkness CA, Thyne SM, Szefler SJ; NIH/NHLBI AsthmaNet. Individualized therapy for persistent asthma in young children. J Allergy Clin Immunol. 2016 Dec;138(6):1608-1618.e12. doi: 10.1016/j.jaci.2016.09.028. Epub 2016 Oct 21.

PUBMED 27777180


Sources of Recruitment
  • Individuals

Number of participants

Number of participants
Number of participants with biosamples


Availability of data and biosamples